Bank of New York Mellon’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-645,973
Closed -$3.9M 4239
2019
Q4
$3.9M Buy
645,973
+7,398
+1% +$44.6K ﹤0.01% 2458
2019
Q3
$2.3M Sell
638,575
-12,017
-2% -$43.3K ﹤0.01% 2677
2019
Q2
$1.74M Buy
650,592
+14,757
+2% +$39.6K ﹤0.01% 2869
2019
Q1
$1.88M Buy
635,835
+14,290
+2% +$42.3K ﹤0.01% 2801
2018
Q4
$988K Sell
621,545
-9,316
-1% -$14.8K ﹤0.01% 3109
2018
Q3
$2.32M Buy
630,861
+9,185
+1% +$33.8K ﹤0.01% 2763
2018
Q2
$1.76M Sell
621,676
-4,993
-0.8% -$14.1K ﹤0.01% 2926
2018
Q1
$2.33M Buy
626,669
+38,850
+7% +$144K ﹤0.01% 2720
2017
Q4
$1.69M Sell
587,819
-17,474
-3% -$50.3K ﹤0.01% 2932
2017
Q3
$2.72M Sell
605,293
-6,341
-1% -$28.5K ﹤0.01% 2654
2017
Q2
$2.81M Buy
611,634
+62,515
+11% +$287K ﹤0.01% 2644
2017
Q1
$2.31M Buy
549,119
+585
+0.1% +$2.46K ﹤0.01% 2765
2016
Q4
$2.27M Buy
548,534
+35,943
+7% +$148K ﹤0.01% 2774
2016
Q3
$4.15M Sell
512,591
-28,960
-5% -$235K ﹤0.01% 2334
2016
Q2
$4.22M Buy
541,551
+259
+0% +$2.02K ﹤0.01% 2294
2016
Q1
$4.18M Sell
541,292
-20,138
-4% -$155K ﹤0.01% 2270
2015
Q4
$6.06M Buy
561,430
+16,393
+3% +$177K ﹤0.01% 2110
2015
Q3
$3.77M Sell
545,037
-100,825
-16% -$697K ﹤0.01% 2394
2015
Q2
$5.72M Buy
645,862
+20,926
+3% +$185K ﹤0.01% 2266
2015
Q1
$6.16M Sell
624,936
-20,976
-3% -$207K ﹤0.01% 2202
2014
Q4
$7.91M Buy
645,912
+8,589
+1% +$105K ﹤0.01% 2055
2014
Q3
$6.36M Buy
637,323
+176,000
+38% +$1.76M ﹤0.01% 2162
2014
Q2
$3.49M Buy
461,323
+2,437
+0.5% +$18.4K ﹤0.01% 2545
2014
Q1
$1.51M Sell
458,886
-764
-0.2% -$2.51K ﹤0.01% 3064
2013
Q4
$1.53M Sell
459,650
-13,475
-3% -$44.7K ﹤0.01% 3050
2013
Q3
$1.43M Buy
473,125
+44,797
+10% +$135K ﹤0.01% 3046
2013
Q2
$3.5M Buy
+428,328
New +$3.5M ﹤0.01% 2405